Get startedLog in
    Picture of Spago Nanomedical AB (publ) logo

    SPAGO — Spago Nanomedical AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Spago Nanomedical Updates On Preclinical Studies Of Tumorad

    Picture of Spago Nanomedical AB (publ) logoSpago Nanomedical AB (publ)
    19/05/2020 08:04
    May 19 (Reuters) - Spago Nanomedical AB (publ)  SPAGO.TE :
    * PRECLINICAL STUDIES SHOW TUMORAD ACCUMULATES IN TUMORS TO
AN
EXTENT WHICH MEANS SUBSTANCE HAS GOOD POTENTIAL TO BECOME
CLINICALLY USEFUL

Source text for Eikon: [ID:https://cisn.co/3bQtDNn]
Further company coverage:  SPAGO.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on Spago Nanomedical AB (publ)

    See all news